Phase 1 dose escalation trial of monotherapy IDE574 expected to begin in 1Q 2026
Targeting to present preclinical data detailing pharmacologic profile and evidence of anti-tumor activity in solid tumor models at a medical conference in 1H 2026
, /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, announced the submission of an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for IDE574, a potential first-in-class KAT6/7 dual inhibitor with high selectivity over related KAT5/8 enzymes. The company is targeting to begin a Phase 1 dose escalation trial of monotherapy IDE574 in the first quarter of 2026.
"IDE574 is a promising potential first-in-class molecule that potently inhibits two tumor-promoting epigenetic modulators, KAT6 and KAT7, while sparing other structurally similar KAT family members. Preclinical studies demonstrate KAT6 and KAT7 collaboratively control lineage-specific tumorigenic transcription factor activity essential for tumor cell proliferation and survival. Dual KAT6/7 inhibition by IDE574 disrupts tumor lineage identity and delivers robust anti-tumor activity in patient-derived lung and breast cancer xenograft models dependent upon lineage-specific transcription factor activity," said Michael White, Ph.D., Chief Scientific Officer of IDEAYA Biosciences.
IDE574 is an equipotent, highly selective, small molecule dual inhibitor of the lysine acetyltransferase (KAT) 6 and 7, both of which have been shown to support cancer cell survival. IND-enabling studies support the potential clinical evaluation of IDE574 monotherapy in patients with hormone receptor-positive breast cancer, lung adenocarcinoma as well as additional opportunities associated with lineage addiction. IDEAYA is targeting to share data from its preclinical work with IDE574 at a medical conference in the first half of 2026.
About IDEAYA Biosciences
IDEAYA is a precision medicine oncology company committed to the discovery, development, and commercialization of transformative therapies for cancer. Our approach integrates expertise in small-molecule drug discovery, structural biology and bioinformatics with robust internal capabilities in identifying and validating translational biomarkers to develop tailored, potentially first-in-class targeted therapies aligned to the genetic drivers of disease. We have built a deep pipeline of product candidates focused on synthetic lethality and antibody-drug conjugates, or ADCs, for molecularly defined solid tumor indications. Our mission is to bring forth the next wave of precision oncology therapies that are more selective, more effective, and deeply personalized with the goal of altering the course of disease and improving clinical outcomes for patients with cancer.
Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements related to (i) the potential therapeutic benefits of IDE574, including combination therapies; (ii) the timing of initiating a Phase 1 dose escalation trial of monotherapy IDE574 and (iii) the timing of presenting pre-clinical data at a medical conference for IDE574. Such forward-looking statements involve substantial risks and uncertainties that could cause IDEAYA's preclinical and clinical development programs, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties inherent in the drug development process, including IDEAYA's programs in early or late stage of development, the process of designing and conducting preclinical and clinical trials, the regulatory approval processes, the timing of regulatory filings, the challenges associated with manufacturing drug products, IDEAYA's ability to successfully establish, protect and defend its intellectual property, and other matters that could affect the sufficiency of existing cash to fund operations. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA's Annual Report on Form 10-K dated February 18, 2025 and any current and periodic reports filed with the U.S. Securities and Exchange Commission.
December 10, 2025 6:00 AM EST | Source: Nexus Uranium Corp.
Vancouver, British Columbia--(Newsfile Corp. - December 10, 2025) - Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: JA7) ("Nexus" or the "Company") is pleased to announce the appointment of Jon Winter to the Company's Advisory Board, effective December 1st, 2025.
Mr. Winter brings more than 40 years of experience in environmental permitting, regulatory affairs, and mine-site operations across North America and Central America. His appointment strengthens Nexus' advisory capabilities as the Company advances its uranium project portfolio through the permitting and development process.
"Jon's extensive experience in uranium permitting and environmental compliance, specifically with respect to the permitting of enCore Energy's Dewey-Burdock project, represents a significant addition to our team," said Jeremy Poirier, Chief Executive Officer. "His hands-on operational background at in-situ uranium facilities, combined with his track record of securing permits from federal and state agencies, will be invaluable as we advance our U.S. uranium projects toward development."
About Jon Winter
Mr. Winter has over 40 years of experience in the extractive industries and public service. He has worked in the mining environmental health and safety field on permits for development projects and operating facilities, site compliance management, ISO 14001 Environmental Management, mine site reclamation, and management of municipal public works.
Mr. Winter has been involved at the operational level at in-situ uranium and surface gold mining operations in Wyoming, South Dakota, Washington State, Colorado, and Honduras. He has been a key team member in the development of permits and approvals from multiple state and federal agencies, including the U.S. Nuclear Regulatory Commission (NRC), Environmental Protection Agency (EPA), Bureau of Land Management (BLM), U.S. Forest Service (USFS), U.S. Fish and Wildlife Service (USF&W), and the U.S. Army Corps of Engineers (USACE).
Mr. Winter holds degrees in Biology and Rangeland Ecology from Mesa State College and the University of Wyoming.
In connection with his appointment, the Company has granted 30,000 restricted share units ("RSUs") to Mr. Winter pursuant to the Company's omnibus equity incentive compensation plan. The RSUs vest equally in 25% tranches over 12 months beginning on the date of grant, and each RSU entitles the holder to one common share of the Company upon vesting. The RSUs and the underlying shares are subject to restrictions on resale and transfer in accordance with applicable securities laws and stock exchange policies, and will be subject to a four-month hold period from the date of grant.
About Nexus Uranium Corp.
Nexus Uranium is a Canadian uranium exploration company focused on mineral exploration and development in the green energy sector. The Company holds five uranium projects in the United States: Chord and Wolf Canyon in South Dakota; South Pass and Great Divide Basin in Wyoming; and Wray Mesa in Utah. These projects have seen extensive historical exploration and are located in prospective development areas. Nexus also holds the Mann Lake uranium project in the Athabasca Basin of northern Saskatchewan, Canada.
Forward-Looking Statements
This news release contains forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the anticipated contributions of the Company's advisory board and the advancement of the Company's uranium projects. Forward-looking information is based on assumptions considered reasonable by management at the date of this news release, including the continued availability of the Company's advisors and management team, and the Company's ability to execute on its business plans. Actual results may differ materially due to risks and uncertainties, including changes in market conditions, regulatory developments, and risks inherent to the mineral exploration industry. The Company undertakes no obligation to update forward-looking statements except as required by law.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the Company's securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The Company's securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277273
2025-12-10 11:0423d ago
2025-12-10 06:0023d ago
RETRANSMISSION: HIVE Digital Technologies Reports November Production of 290 BTC, Achieves 25 EH/s as Tier III+ AI Data Center Growth Accelerates into 2026
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated November 25, 2025 to its short form base shelf prospectus dated October 31, 2025.
December 10, 2025 6:00 AM EST | Source: HIVE Digital Technologies Ltd.
San Antonio, Texas--(Newsfile Corp. - December 10, 2025) - HIVE Digital Technologies Ltd. (TSXV: HIVE) (NASDAQ: HIVE) (FSE: YO0) (the "Company" or "HIVE"), a diversified multinational digital infrastructure company, reports November 2025 Bitcoin production results, highlighted by year-to-date highs in Bitcoin output and all-time highs in global mining capacity, supported by 300 megawatts ("MW") of capacity in Paraguay.
November 2025 Production Highlights
Bitcoin Produced: 290 BTC (up 182% year-over-year from 103 BTC in November 2024)
Average Daily Production: 9.7 BTC/day
Hashrate: Averaged 23.5 Exahash per Second ("EH/s"), peaking at 25.4 EH/s
Fleet Efficiency: 17.5 Joules per Terahash ("J/TH")
BTC per EH/s: 12.3 BTC
HIVE's network share continues to exceed 2% of the global Bitcoin network, reinforcing its position as one of the world's most efficient and sustainable digital-asset operators.
Full Deployment in Paraguay Achieved
In November, two weeks ahead of schedule, the Company commissioned the final ASICs at its Phase 3 Valenzuela campus, bringing the full 300 MW of Paraguay capacity online. This milestone represents 25 EH/s of installed global Bitcoin mining capacity with an average efficiency of approximately 17.5 J/TH.
November highlights include:
7% Hashrate Growth: Increasing from 21.9 EH/s in October to 23.5 EH/s in November.
Record Production: 290 BTC, a year-to-date high.
Building on this momentum, HIVE plans to develop an additional 100 MW hydroelectric-powered data center at its Yguazú campus in early 2026, with full commissioning targeted for calendar Q3 2026. The Company will evaluate the optimal return-on-invested-capital ("ROIC") strategy for this new capacity as it comes online. Once complete, HIVE's total renewable infrastructure footprint will reach 540 MW across three continents, including 400 MW in Paraguay and 140 MW across Canada and Sweden.
In November, HIVE's subsidiary BUZZ High Performance Computing Inc. ("BUZZ HPC"), a Canadian-based leader in high-performance computing, ranked number one worldwide for network download speed in the latest SemiAnalysis ClusterMAX™ 2.0 report, a trusted independent benchmark for GPU cloud platforms.
To meet the global surge in compute demand, the Company is accelerating hyperscaler-ready AI and HPC infrastructure on a renewable-energy backbone as record cash flows from Bitcoin mining are funding Tier I to Tier III+ upgrades across its global footprint.
In Toronto, BUZZ HPC is upgrading its 7.2 MW facility for Tier III+ sovereign AI applications, keeping data and compute domestic through operating 2,000 next-generation GPUs. Parallel upgrades in Boden, Sweden, expand Tier III+ capacity to operate an additional 2,000 GPUs for BUZZ HPC operations. This is further complemented by the 2,000 next-generation GPUs that are coming online in BUZZ's partnership with Bell Canada, with the first shipment of 504 GPUs expected to be operational in calendar Q1 2026.
These strategic expansions position HIVE at the forefront of green-energy AI infrastructure, delivering large-scale, high-efficiency compute across North America and Europe. Plans to convert the HIVE New Brunswick Tier I facility to Tier III+ for hyperscaler co-location are also being advanced, with design development and site planning moving forward.
Management Insights
"As we prepare to enter calendar 2026, there is a global arms race as the demand for compute continues to accelerate," said Executive Chairman Frank Holmes. "Our renewable campuses enable low-cost, rapid deployment in months - not years. With Bitcoin's next cycle and AI demand surging, our dual engine model is positioned to capture both supercycles in real time with cash flow from Bitcoin operations driving exponential HPC growth."
Aydin Kilic, President & CEO, added: "HIVE's Paraguay buildout, expanding our global footprint from 6 to 25 EH/s in just six months, has become our model for future growth and our playbook for creating large-scale, renewable digital infrastructure. With one of the world's most efficient Bitcoin mining fleets at 17.5 J/TH and BUZZ HPC ranked number one globally for AI cloud network download speed, we have created a growth flywheel poised to accelerate even further in 2026 and beyond. Our dual engines of growth in data center development for both Tier I Bitcoin mining and Tier III+ HPC conversion compliment our strategy to maximize ROIC in capital deployment."
About HIVE Digital Technologies Ltd.
Founded in 2017, HIVE Digital Technologies Ltd. is the first publicly listed company to mine digital assets powered exclusively by green energy. Today, HIVE builds and operates next-generation blockchain and AI data centers across Canada, Sweden, and Paraguay, serving both Bitcoin and high-performance computing (HPC) clients. HIVE's twin-turbo engine infrastructure-driven by Bitcoin mining and NVIDIA GPU-accelerated AI computing—delivers scalable, environmentally responsible solutions for the digital economy.
For more information, visit hivedigitaltech.com, or connect with us on:
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Forward-Looking Information
Except for the statements of historical fact, this news release contains "forward-looking information" within the meaning of the applicable Canadian and United States securities legislation and regulations that is based on expectations, estimates and projections as at the date of this news release. "Forward-looking information" in this news release includes but is not limited to: the construction of the Company's site in Yguazu, Paraguay and its potential specifications and performance upon completion, the timing of it becoming operational; hash rash growth projections; business goals and objectives of the Company; the acquisition, deployment and optimization of the mining fleet and equipment; the continued viability of its existing Bitcoin mining operations; the prospectivity of the BUZZ HPC operations and the ability of the Company to successfully expand the infrastructure and operate in this sector, the receipt of government consents; and other forward-looking information concerning the intentions, plans and future actions of the parties to the transactions described herein and the terms thereon.
Factors that could cause actual results to differ materially from those described in such forward-looking information include, but are not limited to: the inability to complete the construction of the Paraguay acquisition on an economic and timely basis and achieve the desired operational performance; the possibility of flaws in the implementation of the Paraguay build-out and energization; the ongoing support and cooperation of local authorities and the Government of Paraguay; the volatility of the digital currency market; the Company's ability to successfully mine digital currency; the Company may not be able to profitably liquidate its current digital currency inventory as required, or at all; a material decline in digital currency prices may have a significant negative impact on the Company's operations; the regulatory environment for cryptocurrency in Canada, the United States and the countries where our mining facilities are located; an inability to apply the Company's data centers to HPC/AI opportunities on a profitable basis; a failure to secure long-term contracts associated with HPC/AI customers on terms which are economic or at all; economic dependence on regulated terms of service and electricity rates; the speculative and competitive nature of the technology sector; dependency on continued growth in blockchain and cryptocurrency usage; lawsuits and other legal proceedings and challenges; government regulations; the global economic climate; dilution; future capital needs and uncertainty of additional financing, including the Company's ability to utilize the Company's ATM Program and the prices at which the Company may sell Common Shares in the ATM Program, as well as capital market conditions in general; risks relating to the strategy of maintaining and increasing Bitcoin holdings and the impact of depreciating Bitcoin prices on working capital; the competitive nature of the industry; currency exchange risks; the need for the Company to manage its planned growth and expansion; the need for continued technology change; the ability to maintain reliable and economical sources of power to run its cryptocurrency mining assets; the impact of energy curtailment or regulatory changes in the energy regimes in the jurisdictions in which the Company operates; protection of proprietary rights; the effect of government regulation and compliance on the Company and the industry; network security risks; the ability of the Company to maintain properly working systems; reliance on key personnel; global economic and financial market deterioration impeding access to capital or increasing the cost of capital; share dilution resulting from the ATM Program and from other equity issuances; the construction and operation of facilities may not occur as currently planned, or at all; expansion may not materialize as currently anticipated, or at all; the digital currency market; the ability to successfully mine digital currency; revenue may not increase as currently anticipated, or at all; it may not be possible to profitably liquidate the current digital currency inventory, or at all; a decline in digital currency prices may have a significant negative impact on operations; an increase in network difficulty may have a significant negative impact on operations; the volatility of digital currency prices; the anticipated growth and sustainability of electricity for the purposes of cryptocurrency mining in the applicable jurisdictions; the inability to maintain reliable and economical sources of power for the Company to operate cryptocurrency mining assets; the risks of an increase in the Company's electricity costs, cost of natural gas, changes in currency exchange rates, energy curtailment or regulatory changes in the energy regimes in the jurisdictions in which the Company operates and the adverse impact on the Company's profitability; the ability to complete current and future financings, any regulations or laws that will prevent the Company from operating its business; historical prices of digital currencies and the ability to mine digital currencies that will be consistent with historical prices; an inability to predict and counteract the effects of pandemics on the business of the Company, including but not limited to the effects of pandemics on the price of digital currencies, capital market conditions, restriction on labour and international travel and supply chains; and, the adoption or expansion of any regulation or law that will prevent the Company from operating its business, or make it more costly to do so; and other related risks as more fully set out in the Company's disclosure documents under the Company's filings at www.sec.gov/EDGAR and www.sedarplus.ca.
The forward-looking information in this news release reflects the Company's current expectations, assumptions, and/or beliefs based on information currently available to the Company. In connection with the forward-looking information contained in this news release, the Company has made assumptions about the Company's objectives, goals or future plans, the timing thereof and related matters. The Company has also assumed that no significant events will occur outside of the Company's normal course of business. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance, and accordingly, undue reliance should not be put on such information due to its inherent uncertainty. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether because of new information, future events or otherwise, other than as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277552
2025-12-10 11:0423d ago
2025-12-10 06:0023d ago
Dark Side Of Weekly Payouts: CONY Is The Lesser Evil Than ULTY
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-10 10:0423d ago
2025-12-10 04:0023d ago
Banks Must Educate as They Innovate: Over a Third of UK Consumers Say Financial Services AI is Moving Too Fast, FIS Research Shows
LONDON--(BUSINESS WIRE)--The UK is experiencing rapid AI adoption in financial services, with 75% of financial firms now using artificial intelligence, up from 58% in 2022, as reported by the Bank of England and Financial Conduct Authority (2024 report).1 But new research from FIS, a leading provider of financial technology, reveals that consumer confidence is failing to keep pace with innovation, creating a widening AI trust gap and an imperative for banks to educate and build trust with their customers.
The FIS consumer survey of 2,000 nationally representative UK adults finds that 33% of consumers have no trust at all in generative AI (GenAI) - virtually unchanged from 30% in 2023 - while an additional 21% report only 'a little trust,' showing that, despite two years of industry deployment, consumer confidence remains stubbornly low. Perhaps more concerning, half (50%) of UK consumers now report that generative AI makes them anxious.
At the same time, over a third (38%) believe banks and financial services companies are innovating too quickly. This suggests that the pace of change may be outstripping public comfort and understanding of emerging technologies.
Early Adopters See the Benefits; Late Adopters See the Risks
Many UK consumers remain unaware of the extent to which AI already underpins their banking experience. While 72% say they have heard of AI chatbots, 43% claim they never use them. Yet AI is also working invisibly in fraud detection systems, loan decisioning, and transaction monitoring, for example - technologies that consumers use daily without even realising it. This behind-the-scenes use of technology may be a missed opportunity to increase familiarity among consumers, educate them of the benefits, and ultimately build trust.
FIS has identified four distinct consumer segments based on technology adoption speed:
Early adopters (13% of consumers) are confident and curious, with 62% highly aware of AI and 66% reporting it has improved their banking experience.
Mainstream adopters (37%) are open but cautious, seeking proof before committing.
Late adopters (37%) remain hesitant, with only 27% having strong AI awareness.
Laggards (13%), the most tech-resistant group, have just 21% awareness and the lowest confidence in AI's benefits.
Across these groups, awareness and trust move hand in hand: those more familiar with AI are more likely to see its advantages, while those less confident remain focused on potential risks.
What’s Holding Consumers Back?
The research highlights how perceptions of risk vary significantly across adoption groups, with later adopters consistently expressing higher levels of concern about security, privacy and transparency. The divide in risk perception is stark: early adopters, who have experienced AI benefits firsthand, show significantly lower levels of concern across every measure. Meanwhile, those with less AI exposure show heightened anxiety about the same technologies:
What are your main concerns about how AI and other emerging technologies are used in banking and financial services?
UK average
Early adopters
Mainstream
adopters
Late
adopters
Laggards
Risk of fraud or identity theft
48%
28%
45%
55%
56%
Data privacy and misuse
46%
27%
45%
52%
53%
Lack of human oversight
46%
26%
43%
53%
56%
Lack of regulation
39%
29%
34%
46%
44%
Lack of transparency about how AI is used
38%
24%
35%
45%
40%
The research also reveals where consumers see AI making its most positive impact: 23% cite fraud detection and prevention, 22% point to identity verification, and 18% value faster customer service, enabled by technology. These priorities suggest consumers are ready to embrace AI that enhances security and convenience, but remain sceptical of AI that demands data sharing or autonomous decision-making.
Kanv Pandit, Head of International Markets - Banking and Payments at FIS commented on the findings: “There’s a clear gap between curiosity and confidence in AI and emerging technologies in the UK. Half of the UK consumers we surveyed don't know how AI could improve their financial lives. AI is already embedded in proven use cases such as fraud detection, faster payments, and personalised recommendations, helping make banking faster and more convenient, but if customers don't understand how it works or how it helps them, trust will never follow.
“The challenge for banks is not just to innovate, but to educate and reassure. Every new technology launch should come with a clear explanation of how it keeps consumers’ money safe and their data protected. Every AI deployment should come with plain-English education about what it does, why it matters, and how it protects customers.”
As AI deployment accelerates across financial services, the research provides critical intelligence for institutions seeking to bridge the gap between technical capability and consumer confidence, showing that the winners in AI won't be the fastest to deploy, but the most trusted.
About the Research
The UK consumer pulse survey builds on FIS' 2023 research into trust in generative AI, enabling year-over-year tracking of consumer attitudes. The 2025 survey was conducted by Opinium Research between 21st and 24th October 2025. Data was collected via an online survey of 2,000 nationally representative UK adults.
About FIS
FIS is a financial technology company providing solutions to financial institutions, businesses, and developers. We unlock financial technology to the world across the money lifecycle underpinning the world’s financial system. Our people are dedicated to advancing the way the world pays, banks and invests, by helping our clients to confidently run, grow, and protect their businesses. Our expertise comes from decades of experience helping financial institutions and businesses of all sizes adapt to meet the needs of their customers by harnessing where reliability meets innovation in financial technology. Headquartered in Jacksonville, Florida, FIS is a member of the Fortune 500® and the S & P 500® Index.
To learn more, visit www.fisglobal.com. Follow FIS on LinkedIn, Facebook and X.
2025-12-10 10:0423d ago
2025-12-10 04:0023d ago
Pheasant Network by PG Labs Raises $2M Seed Round to Accelerate AI-Powered Intent for DeFAI
TORTOLA, British Virgin Islands--(BUSINESS WIRE)---- $ARB #AI--Pheasant Network raised 2M USD led by mint with Ethereum Foundation support to advance AI Intent cross chain tech and expand $PNT and AI routing.
2025-12-10 10:0423d ago
2025-12-10 04:0623d ago
Should You Buy the Invesco QQQ ETF With the Nasdaq Near an All-Time High? History Offers a Clear Answer.
November was a rough month for technology stocks, but the Nasdaq-100 is bouncing back.
The Nasdaq stock exchange is often the preferred destination for early-stage companies looking to go public, because it offers lower listing fees and fewer barriers compared to alternatives like the New York Stock Exchange. That's why technology giants like Amazon (AMZN +0.45%) and Nvidia (NVDA 0.31%) chose to list on the Nasdaq when their businesses started gaining momentum in the late 1990s.
Companies like Amazon and Nvidia have since become trillion-dollar giants on the back of hypergrowth themes like cloud computing, e-commerce, and artificial intelligence (AI). Thanks to their incredible scale, they dominate the Nasdaq-100 index, which features 100 of the largest nonfinancial companies listed on the Nasdaq, and is often a proxy for the performance of the tech sector.
The Nasdaq-100 plummeted by as much as 7% in November, but it has almost fully recovered. In fact, a gain of less than 2% from here will put the index at a new all-time high. The Invesco QQQ Trust (QQQ +0.12%) is an exchange-traded fund (ETF) that tracks the Nasdaq-100 by holding the same stocks and maintaining similar weightings, so is it a good buy right now? History offers a clear answer.
Image source: Getty Images.
Packed with leaders in AI, autonomous driving, robotics, and more
Although the Invesco QQQ ETF is home to 100 different companies, its top 10 holdings alone represent a staggering 55.3% of the value of its entire portfolio. Therefore, not only does it offer a high degree of exposure to technology and technology-adjacent industries, but it's also highly concentrated, with just a select few names having an outsized influence over its performance.
Stock
Invesco ETF Portfolio Weighting
1. Nvidia
9.36%
2. Apple
8.75%
3. Microsoft
7.52%
4. Alphabet
7.51%
5. Broadcom
6.23%
6. Amazon
5.13%
7. Tesla
3.48%
8. Meta Platforms
3.01%
9. Netflix
2.27%
10. Palantir Technologies
2.09%
Data source: Invesco. Portfolio weightings are accurate as of Dec. 4, 2025, and are subject to change.
Nvidia and Broadcom are leading suppliers of chips and components for data centers, which are critical for AI development. Nvidia has also created software and hardware platforms for autonomous vehicles and robots, which could fuel its next phase of growth once the AI infrastructure buildout slows down.
Microsoft, Alphabet, and Amazon have each developed their own AI assistants, but they also operate the three largest cloud computing platforms in the world, which offer a range of services to help businesses develop and deploy AI software. Those services include access to state-of-the-art data centers and ready-made large language models (LLMs), which can be used to accelerate their progress.
Tesla, on the other hand, is one of the world's top manufacturers of electric vehicles (EVs), but investors are more focused on the company's futuristic product platforms like its autonomous robotaxi, the Cybercab, and its humanoid robot called Optimus. The Cybercab is expected to enter mass production in 2026, and Optimus could follow shortly after. Both products could be orders of magnitude more valuable to Tesla than its EV business.
But with other holdings like streaming giant Netflix, e-commerce titan Shopify, food delivery powerhouse DoorDash, and small business software juggernaut Intuit, the Invesco QQQ ETF isn't all about advanced technologies like AI. In fact, it also holds many stocks from outside the tech sector entirely, including Costco Wholesale, PepsiCo, and Starbucks.
Today's Change
(
0.12
%) $
0.77
Current Price
$
625.05
History suggests there is rarely a bad time to invest
The Invesco QQQ ETF has delivered a compound annual return of 10.5% since its inception in 1999, even after accounting for every sell-off, correction, and bear market -- including those triggered by earth-shattering events like the dot-com crash, the global financial crisis, and the COVID-19 pandemic.
Past performance isn't always a reliable indicator of future results, but the Nasdaq-100 tends to trend higher over time, so there is rarely a bad moment to buy the Invesco QQQ ETF as long as investors intend to hold it for a long-term period of at least five years (but the longer, the better). Betting against this index means betting against some of the greatest innovations of our time, many of which have permanently reshaped our lives.
The chart displays the returns of the top five stocks in the Invesco ETF over the past decade alone. The evidence suggests it pays to stay bullish and optimistic:
NVDA data by YCharts
Although AI has fueled blistering returns in some of those stocks over the last few years, other technologies like autonomous vehicles, robotics, and even quantum computing are likely to take over as the dominant drivers of upside sometime in the next 10 years or so. Simply put, technology is constantly evolving, so investors shouldn't be deterred from buying the Invesco QQQ ETF just because the Nasdaq-100 is near an all-time high.
Anthony Di Pizio has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Costco Wholesale, DoorDash, Intuit, Meta Platforms, Microsoft, Netflix, Nvidia, Palantir Technologies, Shopify, Starbucks, and Tesla. The Motley Fool recommends Broadcom and Nasdaq and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
2025-12-10 10:0423d ago
2025-12-10 04:1023d ago
2 Popular Artificial Intelligence (AI) Stocks to Sell Before They Fall 50% and 72% in 2026, According to Wall Street Analysts
These Wall Street analysts expect shares of Palantir and Intel to crash in the next year.
Year to date, Palantir Technologies (PLTR +0.19%) stock has returned 140% and Intel (INTC +0.47%) stock has returned 101%. However, certain Wall Street analysts believe the stocks are wildly overvalued. Following are the most pessimistic 12-month forecasts.
Rishi Jaluria at RBC Capital has set Palantir with a target price of $50 per share. That implies 72% downside from its current share price of $181.
Matt Bryson at Wedbush and Amanda Tan at DBS Bank have set Intel with a target price of $20 per share. That implies 50% downside from its current share price of $40.50.
Here's what investors should know about Palantir and Intel.
Image source: Getty Images.
Palantir Technologies: 72% implied downside
Palantir builds data analytics and artificial intelligence (AI) platforms for customers in the public and private sectors. Its key differentiator is ontology-based software, meaning its products are designed around a decisioning framework made more effective over time by machine learning (ML) models. Use cases span supply chain management, retail inventory optimization, financial fraud detection, and battlefield analytics.
Last year, Forrester Research recognized Palantir as the most capable AI/ML platform on the market, ranking it above Alphabet's Google, Amazon Web Services, and Microsoft Azure. The analysts wrote, "Palantir is quietly becoming one of the largest players in this market." Earlier this year, Forrester ranked Palantir as a leader in AI decisioning platforms.
Glowing recognition from industry analysts has come alongside strong financial results. In the third quarter, Palantir's revenue rose 63% to $1.1 billion, the ninth straight acceleration, and non-GAAP earnings more than doubled to $0.21 per diluted share. Management said strong demand for its artificial intelligence platform was key to its strong performance.
The problem with Palantir is valuation. Shares currently trade at 160 times sales, which makes it the most expensive stock in the S&P 500 by a wide margin. AppLovin is the next closest stock at 57 times sales. That means Palantir could lose nearly two-thirds of its value and still be the most expensive stock in the index.
Palantir has a strong competitive position in AI platforms, a market forecast to grow at 38% annually through 2033. But the valuation "seems unsustainable," according to Rishi Jaluria at RBC Capital. I completely agree. Palantir shares may move higher in the coming months, but a major correction is almost inevitable at some point. Investors should either avoid the stock or keep any positions very small.
Today's Change
(
0.19
%) $
0.35
Current Price
$
181.84
Intel: 50% implied downside
Intel is the market leader in central processing unit (CPU) sales across personal computers and data center servers, but the company has lost substantial market share in both CPU categories to AMD and Arm. Intel sees an opportunity to benefit as AI drives demand for CPUs, but the company has so far failed to capitalize. In fact, it famously passed on an opportunity to invest in OpenAI in 2017.
Meanwhile, Intel Foundry, the external chip manufacturing business that was launched in 2021, only recently won its first major customer (reportedly Microsoft). Initially, Intel aimed to surpass Samsung as the second-largest foundry by the end of the decade, but the odds of that happening are quite slim. Intel's history of execution missteps is unlikely to inspire confidence.
Importantly, Intel earlier this year said it may have to discontinue development of its next-generation 14A chip process technology and all leading-edge nodes thereafter if it cannot "secure a significant external customer." It's unclear whether the recent customer win will provide sufficient capital to prevent that outcome, so the company may yet have to exit the chip manufacturing business.
Intel reported 3% sales growth in the recent quarter. Meanwhile, AMD and Arm reported sales growth of 36% and 34%, respectively. Despite sluggish growth, Intel shares currently trade at 3.3 times sales, a premium to the five-year average of 2.4 times sales. I doubt the stock will fall 50%, but the combination of market share losses and a valuation that is high by historical standards is a good reason for investors to avoid the stock.
Trevor Jennewine has positions in Amazon and Palantir Technologies. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Amazon, Intel, Microsoft, and Palantir Technologies. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
2025-12-10 10:0423d ago
2025-12-10 04:1523d ago
2 Top Growth Stocks to Buy and Hold for the Next 10 Years
Both of these companies have plenty of room to grow.
If you had invested in either Netflix (NFLX 0.08%) or Shopify (SHOP +0.93%) a decade ago and held on, you would have earned outstanding returns. Both companies have significantly outperformed broader equities since 2015.
And here's the best news about these market leaders: They still have significant room to grow in their respective industries and boast outstanding moats that will help them, once again, deliver superior returns through 2035.
Let's take a closer look.
Image source: Getty Images.
1. Netflix
Netflix is the undisputed leader in streaming, although other companies have tried to steal its market share. In fact, due to increased competition and other factors, Netflix's revenue growth dipped significantly and was in the low single digits at some point a couple of years ago.
However, the company has bounced back from that thanks to important changes it made to its business. And amid all that, Netflix's free cash flow continued to move in the right direction.
NFLX Revenue (Quarterly YoY Growth) data by YCharts
It proved through this ordeal that it can thrive even in a highly competitive landscape. And now, Netflix has plenty of growth fuel that should still allow it to deliver superior returns through the next decade.
The company's revenue growth is still fueled partly by an increasing number of paid subscribers, a deeper ecosystem that also grants it access to even more data to pick the right content to license or create, thereby attracting even more customers -- a wonderful example of the network effect.
Today's Change
(
-0.08
%) $
-0.08
Current Price
$
96.71
Netflix is also branching out into new areas, including sports. It's a niche of the streaming market currently dominated by other successful media giants. Disney-owned ESPN comes to mind. However, Netflix is slowly making moves in this space, including plans to bid on global rights to host the UEFA Champions League. If it were to win this bidding war, Netflix might be able to make significant progress in regions outside the U.S.
That's because, although the UEFA Champions League isn't nearly as popular as, say, the NFL in the U.S., it is one of the most-watched sports competitions in the world. Between this move and Netflix's decision to show Christmas Day NFL Games, the company is clearly looking to gain market share in an area where it currently lags, efforts that, over the next 10 years, could significantly boost paid subscribers, engagement, and, of course, revenue, including from ads.
This highlights an important point: Netflix has barely scratched the surface of its addressable market, which it estimated to be more than $650 billion. This dwarfs its trailing-12-month revenue of $43.3 billion. The company's recently announced acquisition of Warner Bros. Discovery for $72 billion in equity value (or a total of $82.7 billion in enterprise value) could grant Netflix even more opportunities. Netflix has plenty of growth fuel that could allow it to beat the market through 2035.
2. Shopify
Shopify has been an innovator since its early days. The e-commerce specialist now stands as one of the leaders in its niche, helping merchants set up online storefronts. Shopify makes the process easy. It offers basic, highly customizable templates that don't require any coding knowledge. And that's just the beginning.
Shopify offers a comprehensive suite of services that simplify the operations of its clients once they have established their online stores, including shipping solutions, inventory management, analytical tools, payment processing, marketing, and the ability to sell products across social media channels, among others. The interconnected nature of these offerings, along with the time, money, and effort required to set up all of them, makes it difficult for Shopify's clients to leave the platform, resulting in high switching costs.
Today's Change
(
0.93
%) $
1.48
Current Price
$
159.89
Shopify has found tremendous success. Revenue has grown -- and continues to grow -- rapidly.
SHOP Revenue (Annual) data by YCharts
The company isn't yet consistently profitable, but it has also made significant progress in that area. It got rid of its low-margin logistics business a couple of years ago and has since recorded stronger profits, margins, and free cash flow. Shopify is on a roll, and over the next 10 years, the company should ride the massive e-commerce tailwind. Online transactions still account for less than 20% of total retail transactions in the U.S.
Meanwhile, Shopify is still making moves, including an agreement with OpenAI that will enable its merchants to sell products directly on ChatGPT, potentially boosting its gross merchandise volume and revenue. In short, Shopify has excellent prospects. Those who hold on to its shares through the next decade likely will be happy they did so.
2025-12-10 10:0423d ago
2025-12-10 04:1523d ago
Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment
-Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a randomized, double-blind, placebo-controlled, multicenter Phase III clinical trial.
, /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that its New Drug Application (NDA) for denifanstat (ASC40), a first-in-class, once-daily oral small molecule fatty acid synthase (FASN) inhibitor for the treatment of moderate-to-severe acne vulgaris, has been accepted by the China National Medical Products Administration (NMPA).
"Acceptance of this NDA is an important milestone in our efforts to provide a potentially groundbreaking therapeutic approach for the treatment of moderate-to-severe acne," said Jinzi Jason Wu, Ph.D., Founder, Chairman and CEO of Ascletis, "We are excited denifanstat (ASC40) is only one step away from the commercialization."
Ascletis has completed Phase II (NCT05104125) and Phase III (NCT06192264) studies of denifanstat (ASC40) for the treatment of moderate-to-severe acne vulgaris.
In the Phase III study, denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo. Denifanstat (ASC40) demonstrated a favorable safety and tolerability profile. All denifanstat (ASC40)-related treatment-emergent adverse events (TEAEs) were mild (Grade 1) or moderate (Grade 2). There were no denifanstat (ASC40)-related Grade 3 or 4 TEAEs and no denifanstat (ASC40)-related serious adverse events (SAEs). There were no denifanstat (ASC40)-related permanent treatment discontinuations or withdrawals observed.
The Phase III study results were presented as an oral presentation at the European Academy of Dermatology and Venereology (EADV) Congress 2025 in Paris, France on September 17, 2025 (link).
The Company recently completed the pre-NDA consultation with the China NMPA for denifanstat (ASC40) for the treatment of moderate-to-severe acne vulgaris and received positive feedback from NMPA.
Ascletis licensed denifanstat (ASC40) from Sagimet Biosciences Inc. (Nasdaq: SGMT) for exclusive rights in Greater China.
About Ascletis Pharma Inc.
Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases. Utilizing its proprietary Artificial Intelligence-Assisted Structure-Based Drug Discovery (AISBDD) and Ultra-Long-Acting Platform (ULAP) technologies as well as Peptide Oral Transport ENhancement Technology (POTENT), Ascletis has developed multiple drug candidates in-house, including both small molecules and peptides, such as its lead program, ASC30, a small molecule GLP-1R agonist designed to be administered once daily orally and once monthly to once quarterly subcutaneously as a treatment therapy and a maintenance therapy for chronic weight management; ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist, ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist and ASC37, an oral GLP-1R/GIPR/GCGR triple peptide agonist for chronic weight management. Ascletis is listed on the Hong Kong Stock Exchange (1672.HK).
For more information, please visit www.ascletis.com.
Contact:
Peter Vozzo
ICR Healthcare
443-231-0505 (U.S.)
[email protected]
Ascletis Pharma Inc. PR and IR teams
+86-181-0650-9129 (China)
[email protected]
[email protected]
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-10 10:0423d ago
2025-12-10 04:2823d ago
Vestis Corp.: Revenue Growth Needs To Recover First
SummaryVestis Corp. remains a hold as fundamentals are weak and revenue continues to decline, justifying its discounted valuation.FY25 revenue, adjusted for the extra week, fell 3.5% y/y; gross margin contracted 366 bps, and net loss reached $40.2 million.FY26 guidance implies margin stabilization via a $75 million cost savings program, but the full benefit materializes in FY27.Persistent high churn, loss of quality accounts, and lack of top-line recovery limit any near-term re-rating potential for VSTS. Morsa Images/DigitalVision via Getty Images
Investment Overview I wrote about Vestis Corp. (VSTS) previously with a hold rating, as there were no tangible signs of an immediate turnaround. I am still holding rated for VSTS, as I don’t see any
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Quick Insights
Recommended For You
2025-12-10 10:0423d ago
2025-12-10 04:3023d ago
Should You Forget High-Yield AGNC Investment and Buy W.P. Carey Instead?
AGNC Investment and W.P. Carey are both dividend cutters; here's why one is a better bet for dividend lovers.
Dividend investors love high-yield stocks and can often get so enamored of a yield that they overlook important facts about an investment. AGNC Investment (AGNC 1.43%) is a good example of this: Its huge 13.7% yield is so enticing that many investors overlook the fact that it is an unreliable dividend payer.
Meanwhile, a dividend cut at W.P. Carey (WPC 0.17%) in 2023 will often leave it on the sidelines despite an attractive 5.5% yield. Here's why most long-term income investors will be better off with W.P. Carey than AGNC Investment.
What are you looking for?
If you are like most dividend investors, your goal is to use the income generated by your portfolio to help support you during retirement. What you are likely trying to find are stocks that have attractive yields backed by dividends that have an opportunity to grow over time. This approach to investing has proved attractive and successful for generations.
Image source: Getty Images.
However, there are two pieces to the equation that you must balance. How much dividend yield do you need, and how much risk are you willing to take on? The biggest risk is a dividend cut, particularly if you are using the income you generate to cover essential living expenses. This is where AGNC Investment should fall off most dividend investors' radar screens.
AGNC Investment is a mortgage real estate investment trust (mREIT). It is a fairly complex niche within the REIT sector, known for offering extremely high yields. AGNC's yield, as noted above, is a huge 13.7%.
What's backing that yield is a portfolio of mortgages that have been pooled together into bond-like securities. There are numerous moving parts involved, including housing market dynamics, mortgage repayment rates, and interest rates, among others. In some ways, AGNC is essentially managing a portfolio of mortgage-backed securities.
AGNC data by YCharts.
Although the yield is huge, dividend investors shouldn't get too excited. As the chart above highlights, the payout has been highly volatile over time, though in recent years it's been in one direction -- down. It isn't a bad company, per se; it just isn't a particularly reliable dividend stock if your goal is to generate a reliable income stream.
Not all dividend cuts are the same
The thing is, it is fairly normal for mortgage REITs like AGNC to cut their dividends. They also raise them at times. However, fluctuating dividends make budgeting impossible if you rely on them to cover your living expenses.
But don't overlook all REITs that have cut their dividends, with property-owning REIT W.P. Carey being a prime example of a dividend cutter you might want to buy today.
In 2023, W.P. Carey trimmed its dividend. It was just one year shy of reaching 25 years of consecutive annual dividend increases. Something terrible must have happened, right?
Not really. Management and the board of directors made a tough decision to sell a number of properties and exit the troubled office sector in a single swift move. It was a large enough change that the dividend had to be reset lower.
WPC data by YCharts.
This decision was made from a position of strength, as the company began to raise the dividend in the very next quarter. It has been increased every quarter since, which was the same cadence that existed before the cut.
Moreover, W.P. Carey used the proceeds from the office sale to invest in new industrial, warehouse, and retail properties. The property owning REIT's growth has actually picked up steam, as shown by management raising its full-year forecast when it announced third-quarter 2025 earnings.
Given the long history of dividend increases before the office exit and the swift return to dividend growth, W.P. Carey and its healthy 5.5% yield are actually quite attractive. Yes, you have to get over the dividend cut. But if you do, you will likely find you like what you see.
High yields are bad, and dividend cuts are good?
Don't read too far into the point being made here. Not all high-yield stocks are risky dividend investments. Nonetheless, AGNC remains an unreliable income generator that most dividend investors will likely want to avoid, given its history of dividend cuts.
However, don't just ignore an attractive business because of a dividend cut. W.P. Carey is a testament to this, with its return to dividend growth indicating that the cut was strategic, and it appears to have positioned the company well for the future.
2025-12-10 10:0423d ago
2025-12-10 04:3023d ago
Devon: Deep Value Buy Supported By Capital Efficiency/Higher Gas Prices
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
The analysis is provided exclusively for informational purposes and should not be considered professional investment advice. Before investing, please conduct personal in-depth research and utmost due diligence, as there are many risks associated with the trade, including capital loss.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-10 10:0423d ago
2025-12-10 04:3223d ago
Viavi Is Building A More Durable Business, And The Market Hasn't Fully Noticed
SummaryViavi Solutions is positioned for growth and margin expansion, driven by the Spirent acquisition and strong NSE segment momentum.Q1 FY26 results showed 26% YoY revenue growth, 60% non-GAAP gross margin, and 15.7% operating margin, reflecting structural improvements.Spirent assets add ~$200M annual run-rate, diversify revenue streams, and enhance margin stability by increasing exposure to higher-quality lab and security testing.I expect a stock rerating as integration progresses, margins stabilize, and cash flow supports leverage; recommend buying before Q2 results. Erik Isakson/DigitalVision via Getty Images
I like Viavi Solutions Inc. (VIAV) because it is starting to carry multiple engines that can support its growth, margin expansion, and better cash generation. Back in September, I highlighted the fact
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Quick Insights
Recommended For You
2025-12-10 10:0423d ago
2025-12-10 04:3823d ago
Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-10 10:0423d ago
2025-12-10 04:4323d ago
Aegon to become Transamerica and relocate to the U.S. The stock dives.
The insurer Aegon on Wednesday it's relocating its headquarters from the Netherlands to the U.S. and renaming itself Transamerica, as part of its ambition to become a leading U.S. life insurance and retirement company.
2025-12-10 10:0423d ago
2025-12-10 04:4423d ago
Airbus CEO says Boeing likely to win order race this year
Airbus CEO Guillaume Faury conceded likely defeat in the annual order race against Boeing on Wednesday, saying it was possible Boeing would win for the first time in six years, helped by settlements over U.S. tariff disputes.
2025-12-10 10:0423d ago
2025-12-10 04:4723d ago
Alibaba Group Holding Limited (BABA) September Quarter 2025 Results Earnings Call Transcript
Alibaba Group Holding Limited (BABA) September Quarter 2025 Results Earnings Conference November 25, 2025 7:30 AM ET
Company Participants
Fan Jiang - Chief Executive Officer of Alibaba E- commerce Business Group
Hong Xu - Chief Financial Officer
Lydia Lu - Head of Investor Relations
Yongming Wu - CEO, Head of Core E-Commerce Business & Director
Conference Call Participants
Alex C. Yao - JPMorgan Chase & Co, Research Division
Ellie Jiang - Macquarie Research
Gary Yu - Morgan Stanley, Research Division
Jialong Shi - Nomura Securities Co. Ltd., Research Division
Kenneth Fong - UBS Investment Bank, Research Division
Ronald Keung - Goldman Sachs Group, Inc., Research Division
Operator
Good day, ladies and gentlemen. Thank you for standing by. Welcome to Alibaba Group's September Quarter 2025 Results Conference Call.
[Operator Instructions] I would now like to turn the call over to Lydia Lu, Head of Investor Relations of Alibaba Group. Please go ahead.
Lydia Lu
Thank you. Good day, everyone. Welcome to our September quarter 2025 earnings conference call. With me today from Alibaba are Joe Tsai, Chairman; Eddie Wu, Chief Executive Officer; Toby Xu, Chief Financial Officer; Jiang Fan, Chief Executive Officer of Alibaba E-commerce Business Group.
I would like to remind you that this call is also being webcast on our corporate website. A replay of the call will be available on our website later today.
Just a few forward-looking statements before we begin today. Today's discussions may contain forward-looking statements, particularly statements about our business and financial results that are subject to risks and uncertainties, which could cause actual results to differ materially from those contained in the forward-looking statements.
Please refer to the safe harbor statements that appear in our press release and investor presentation provided today. Please note that certain financial measures that we use on this call
2025-12-10 10:0423d ago
2025-12-10 04:4823d ago
Air India admits compliance culture needs overhaul after flying Airbus without permit
An Air India investigation into why one of its Airbus planes conducted eight commercial flights without an airworthiness permit found "systemic failures", a company document showed, putting the lives of hundreds of passengers at risk.
2025-12-10 10:0423d ago
2025-12-10 05:0023d ago
Verisk, KYND Expand Collaboration to Strengthen Cyber Resilience for Insurers
KYND cyber intelligence integrates into Verisk’s Rulebook, as new KYND research reveals 80 percent of the UK’s top retailers are vulnerable to cyber threats
December 10, 2025 05:00 ET
| Source:
Verisk Analytics, Inc.
LONDON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, announced today an expansion of its strategic collaboration with KYND to bring enriched cyber risk intelligence to the insurance market.
KYND’s cyber risk insights are now integrated into Verisk’s Rulebook platform, which supports pricing, underwriting and distribution services for all major classes of business. By combining Verisk’s global insurance expertise with KYND’s advanced cyber intelligence, this product integration provides insurers and brokers with seamless access to actionable intelligence, enabling more informed underwriting and risk management decisions.
Holiday Season Brings Heightened Cyber Risks
This expanded collaboration comes as new research from KYND reveals that 80 percent of the UK’s top 50 retailers are exposed to at least one critical cyber vulnerability, with more than a third facing simultaneous risks across all five major categories: ransomware, outdated software, vulnerable services, email security flaws and certificate issues.
“This research reveals that cyber threats are escalating across consumer-facing industries, especially ahead of the holiday season. Retailers hold vast customer data and operate complex supply chains, making them prime targets,” said Andy Thomas, CEO and Founder of KYND. “Our mission is simple: make complex cyber risks easy to see, understand and underwrite. We look forward to supporting insurers alongside Verisk with this collaboration.”
Driving Cyber Resilience Across the Insurance Ecosystem
Verisk aims to build resilience across the insurance value chain, centered on data-driven innovation and advanced technology. This collaboration with KYND reflects a shared commitment to enhancing the tools and insights available to the market, ensuring it can keep pace with the ever-changing nature of cyber threats.
“This deeper collaboration marks a step change in how cyber risk can be understood and managed across the insurance value chain,” said Tim Rayner, CEO, Verisk Specialty Business Solutions. “With KYND’s intelligence embedded into Rulebook, we’re empowering our clients to make faster, better-informed decisions to modernize commercial underwriting and strengthen resilience through data-driven insights. This is just the first of many ways our collaboration with KYND will deliver added value to Verisk’s clients, helping them stay ahead in an evolving cyber risk landscape.”
To learn more about Verisk and KYND’s strategic partnership, please visit: Verisk’s Sequel hub.
ENDS
About Verisk
Verisk (Nasdaq: VRSK) is a leading strategic data analytics and technology partner to the global insurance industry. It empowers clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, catastrophic events, sustainability and political issues. Through advanced data analytics, software, scientific research and deep industry knowledge, Verisk helps build global resilience for individuals, communities and businesses. With teams across more than 20 countries, Verisk consistently earns certification by Great Place to Work and fosters an inclusive culture where all team members feel they belong. For more, visit Verisk.com and the Verisk Newsroom.
About KYND
Founded in 2018 with a mission to help organisations see, understand, and manage cyber risks more easily and quickly than ever before, KYND has become a trusted cyber risk management partner to the insurance industry. It delivers actionable cyber risk intelligence combined with expert advisory services to support informed decision-making across the cyber insurance ecosystem.
Award-winning Iris datalink service is paving the way to trajectory-based operations, which can cut emissions and enhance efficiency for European airlines
December 10, 2025 05:00 ET
| Source:
Viasat, Inc.
ROME, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Viasat Inc., a global leader in satellite communications, today announced that ITA Airways, Italy’s reference carrier, is taking to the sky equipped with Iris technology.
The award-winning European Space Agency (ESA) Iris programme, within ESA Connectivity and Secure Communications, is led by Viasat and takes advantage of next-generation satellite technologies to help modernize Air Traffic Management (ATM).
The service is underpinned by Iris Service Provider and key project partner ESSP, who holds the EASA certification for Iris services provision and has onboarded 19 leading Air Navigation Service Providers (ANSPs) for the Pre-commercial Flights phase, a crucial validation period ahead of deployment. This phase will conclude by the end of 2025. Starting in 2026, the commercial phase will begin with the goal of onboarding 28 ‘Single Europan Sky (SES) 2+’ ANSPs by 2032, supporting operations of more than 1,100 Iris-capable aircraft flying in Europe.
The Iris programme puts the Single European Sky initiative, which aims to reform ATM in Europe, into action, with ITA Airways one of several airlines leading the way. The Iris capability will initially be rolled out on four ITA Airways Airbus A320neo aircraft.
Iris will enable ITA Airways to unlock increased operational efficiencies, achieving improvements in fuel burn and reductions in emissions, as well as contributing to improved airspace modernization across Europe. This is critical in the industry’s continued path towards net zero and 4D trajectory-based operations.
Offered as a fully developed and certified capability by Airbus on the A320 and A330 series aircraft, Iris enables initial 4D trajectory-based operations to share trajectory and intent-based operational information. This enables airlines to avoid holding patterns, calculate the shortest available routes, cruise at optimum altitudes, and benefit from continuous climb and descent pathways. It also paves the way for multilink data link communications using both VDL2 and Iris SATCOM methods, which is critical to modernizing ATM. Iris is powered by Viasat’s SwiftBroadband-Safety (SB-S) connectivity platform.
ITA Airways will operate Iris enabled flights on routes from Milan and Rome to destinations across Europe.
Joerg Eberhart, CEO and General Manager of ITA Airways, said “The introduction of Iris technology on our aircraft represents a significant step forward in enhancing operational efficiency and environmental sustainability.
“At ITA Airways, we are deeply committed to supporting the modernization of European airspace as part of the roadmap toward the Single European Sky, and to playing an active role in the advancement of Air Traffic Management. Through this partnership with Viasat, ESA, and ESSP, we will improve flight punctuality, optimize fuel consumption, and further reduce emissions.
“This initiative perfectly complements our ongoing fleet renewal programme, which already comprises 69% of new-generation aircraft — delivering greater value to our passengers and contributing to a more sustainable future for air travel in Italy and across Europe.”
Joel Klooster, SVP, Flight Safety and Advanced Air Mobility at Viasat, said: “We’re thrilled to see Iris taking to the skies on ITA Airways’ flights across Europe. ITA has been committed to the goals of the Single European Skies initiative for a long time. It’s been fantastic to work so closely with them, as well as our partners ESA and ESSP, to bring the benefits of Iris’ next-generation technology to more flights and passengers across Europe. We look forward to seeing success with these flights: and to rolling out the programme across more routes and airlines soon.”
Laurent Jaffart, Director of ESA’s Connectivity and Secure Communications, said: “With the addition of ITA Airways to the Iris service, another milestone has been achieved in supporting the European Commission’s Single European Sky vision for an efficient and environmentally friendly European airspace. The adoption of Iris is a key space-based solution for European Air Traffic Management, which will – in turn – pave the way for global use. By supporting Iris through an ESA public-private partnership, we are delighted to combine our expertise with those of leading aviation actors across the continent and beyond it.”
Charlotte Neyret, CEO at ESSP, said: “We are thrilled that ITA Airways is now using the Iris Service, marking a major step forward expanding operations across Europe. This is a strategic milestone that highlights the increasing pace of adoption and the growing relevance of Iris in European aviation. Having an additional leading European airline onboard strengthens the network, extends Iris usage across more airspace, and confirms the growing trust in the service's reliability and impact. It’s a win that reflects both progress and potential, opening new doors for growth throughout the region.”
In recent years, the Iris programme has been developing globally. The Iris SATCOM Global Solution will focus on the technologies and certification required to share the fuel, CO2, and congestion-saving benefits.
Iris is now ready to be assessed and expanded for use in other global regions such as Asia and the Americas. By 2028, Iris will be well placed to enable flight optimisation across the globe, making flights greener and more efficient.
About ITA Airways
ITA Airways is the Italian reference carrier. The Company is 59% owned by the Ministry of Economy and Finance and 41% by Deutsche Lufthansa AG. ITA Airways operates both passenger and cargo air transport services, providing Italy with high-quality connectivity to international destinations, supporting tourism and foreign trade, as well as domestic connectivity within the country, also leveraging integrated mobility.
Through strong digitization of processes to ensure the best possible experience and personalized services, ITA Airways places customer service at the core of its strategy. This is combined with a commitment to sustainability, which encompasses environmental aspects (such as a young, technologically advanced fleet to reduce environmental impact), social aspects (a strong focus on its employees and the communities in which it operates), and governance aspects (integrating sustainability into internal strategies and processes).
For press information:
Pietro Caldaroni, Chief Communication Officer
Mail: [email protected]
About Viasat
Viasat is a global communications company that believes everyone and everything in the world can be connected. With offices in 24 countries around the world, our mission shapes how consumers, businesses, governments and militaries around the world communicate and connect. Viasat is developing the ultimate global communications network to power high-quality, reliable, secure, affordable, fast connections to positively impact people’s lives anywhere they are—on the ground, in the air or at sea, while building a sustainable future in space. In May 2023, Viasat completed its acquisition of Inmarsat, combining the teams, technologies and resources of the two companies to create a new global communications partner. Learn more at www.viasat.com, the Viasat News Room or follow us on LinkedIn, X, Instagram, Facebook, Bluesky, Threads, and YouTube.
Viasat, Inc. Contacts:
Scott Goryl, External Communications, Corporate & Commercial Services, [email protected]
Lisa Curran/Peter Lopez, Investor Relations, [email protected]
About ESSP
ESSP SAS (European Satellite Services Provider) is a company that provides space-based Communication, Navigation and Surveillance (CNS) services to different sectors, and in particular for aviation to enhance the safety and efficiency of the Air Traffic Management. ESSP is owned by 7 keys European ANSPs (Air Navigation Service Providers). As a multi-service CNS provider, ESSP operates complex space-based systems and delivers critical services under strict regulation conditions. ESSP, is a private company certified by EASA in Navigation and Communication satellite-based service provision.
Our mission is to boost the potential of space-based technologies in critical operations, offering safe and secure services for greener and more connected worlds. We enable satellite technologies to power today’s transport solutions around the world, providing essential 24/7 services to air navigation service providers and airspace users. ESSP offers specific engineering expertise including performance and network management of the latest space-based technologies such as but not limited to:
GNSS for NavigationDatalink for CommunicationsTechnology in Surveillance
Learn more at www.essp-sas.eu or follow us on LinkedIn, X, Bluesky or YouTube.
About the European Space Agency
The European Space Agency (ESA) provides Europe’s gateway to space.
ESA is an intergovernmental organization, created in 1975, with the mission to shape the development of Europe’s space capability and ensure that investment in space delivers benefits to the citizens of Europe and the world.
ESA has 23 Member States: Austria, Belgium, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Spain, Sweden, Switzerland and the United Kingdom. Latvia, Lithuania, Slovakia and Slovenia are Associate Members.
ESA has now established formal cooperation agreements with all Member States of the European Union that are not ESA members.
By coordinating the financial and intellectual resources of its members, ESA can undertake programmes and activities far beyond the scope of any single European country.
Learn more about ESA at www.esa.intLearn more about ESA’s contribution to Iris at connectivity.esa.int/iris-satellite-communication-air-traffic-management
2025-12-10 10:0423d ago
2025-12-10 05:0023d ago
Meta's New A.I. Superstars Are Chafing Against the Rest of the Company
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in AVGO, over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-10 09:0423d ago
2025-12-10 03:0923d ago
GSK drug for aggressive lung cancer wins US orphan status
About Ian Lyall
Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive's editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually.
Prior to Proactive, Ian helped lead the business output at the Daily... Read more
About the publisher
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.
Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.
We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.
The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.
Use of technology
Proactive has always been a forward looking and enthusiastic technology adopter.
Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.
Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.
2025-12-10 09:0423d ago
2025-12-10 03:1523d ago
HEALWELL AI Appoints Ian Kidson to Board of Directors
December 10, 2025 3:15 AM EST | Source: HEALWELL AI
HEALWELL appoints Ian Kidson, a seasoned executive and director with decades of financial, governance, and healthcare corporate leadership experience, to its Board of Directors to help advance the Company's mission of improving healthcare and saving lives through the early identification and detection of disease.Toronto, Ontario--(Newsfile Corp. - December 10, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce the appointment of Ian Kidson to its Board of Directors, effective immediately.
Mr. Kidson is an experienced corporate director and senior executive with a distinguished career spanning both private and public sectors in Canada and the U.S. He currently serves on the board of directors of Lakeshore Recycling Systems, a leading waste diversion, recycling, and portable services provider in the U.S.
From 2019 to 2021, Mr. Kidson was Chief Financial Officer at Docebo Inc. (TSX: DCBO), a publicly listed global learning technology company. He also served as Chief Financial Officer and Chief Executive Officer at Apollo Health Corp. (Previously Acasta Enterprises Inc.), a TSX-listed company. Prior to Apollo, Mr. Kidson was Executive Vice President and Chief Financial Officer of Progressive Waste Solutions Ltd., a publicly traded waste management company that successfully merged with Waste Connections Inc. in 2016.
Earlier in his career, Mr. Kidson held senior leadership roles in capital markets, serving as Managing Director at CIBC Wood Gundy from 1984 to 2000 and later as Managing Director at TD Capital Mezzanine Partners from 2000 to 2011. He holds a Bachelor of Science and an MBA in Accounting and Finance from McMaster University in Hamilton, Ontario.
"We are thrilled to welcome Ian Kidson to HEALWELL's Board of Directors," said Hamed Shahbazi, Chair of HEALWELL AI. "Ian brings an exceptional track record of leadership across public companies, capital markets, and the healthcare sector. His depth of financial expertise and proven ability to guide organizations through periods of growth and transformation will be invaluable as HEALWELL continues to execute on its mission of improving healthcare through the early identification and detection of disease."
James Lee
Chief Executive Officer
HEALWELL AI Inc.
About HEALWELL AI
HEALWELL is a healthcare artificial intelligence company focused on preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF". To learn more about HEALWELL, please visit https://healwell.ai/.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277562
2025-12-10 09:0423d ago
2025-12-10 03:1523d ago
Meta Platforms: Still Waiting For A Breakthrough And Revaluation (Rating Upgrade)
Meta Platforms is upgraded to Buy, reflecting strong core business metrics and undervaluation relative to historic P/E multiples. META's Family of Apps segment delivers robust profitability, with net profit margin above 30% and ROIC exceeding 23%, underscoring competitive advantage. Heavy CapEx—$62.7B TTM, 84% of net profit—targets AI and Reality Labs, but success in Reality Labs remains elusive and is a key risk.
2025-12-10 09:0423d ago
2025-12-10 03:2123d ago
Microsoft makes $17.5bn bet on India with its biggest ever investment in Asia
About Ian Lyall
Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive's editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually.
Prior to Proactive, Ian helped lead the business output at the Daily... Read more
About the publisher
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.
Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.
We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.
The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.
Use of technology
Proactive has always been a forward looking and enthusiastic technology adopter.
Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.
Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.
2025-12-10 09:0423d ago
2025-12-10 03:2223d ago
LuxExperience: Selling THE OUTNET May Be The 'Smart Bad Deal'
LuxExperience remains a compelling 'Buy' with a low 0.35x EV/S multiple and a multi-year recovery plan underway. Divestiture of THE OUTNET for $30 million streamlines operations, enabling focus on full-price segments and margin improvement. Q1 FY 2026 results show margin expansion, disciplined SG&A reduction, and strong AOV growth, particularly at MyTheresa and NET-A-PORTER.
2025-12-10 09:0423d ago
2025-12-10 03:2623d ago
Warner Bros takeover: Tencent shelves Paramount backing amid potential scrutiny
About Ian Lyall
Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive's editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually.
Prior to Proactive, Ian helped lead the business output at the Daily... Read more
About the publisher
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.
Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.
We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.
The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.
Use of technology
Proactive has always been a forward looking and enthusiastic technology adopter.
Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.
Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.
2025-12-10 09:0423d ago
2025-12-10 03:2623d ago
Core & Main: Performance In Q3 Was Impressive, All Things Considered, But With Limited Upside
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-10 09:0423d ago
2025-12-10 03:3023d ago
Hims & Hers Brings Comprehensive Weight Loss Programme to the UK
LONDON--(BUSINESS WIRE)--Hims & Hers is deepening its commitment to the UK by bringing access to its comprehensive Weight Loss Programme to customers. This expansion includes the official introduction of the Hers platform, helping eligible women across the UK receive access to this holistic weight management care.
Sixty four percent of UK adults are overweight or living with obesity, yet access to GLP-1 treatment plans remains challenging on the NHS, and via the private sector due to surging demand and escalating costs. Removing barriers to care, the Hims & Hers digital platform provides eligible British women and men seamless access to its comprehensive, doctor-designed Weight Loss Programme.
Following a thorough, and clinically robust intake assessment conducted by GMC-registered doctors, eligible customers now have access to transparent pricing and personalised weight management programmes, which may include branded GLP-1 options, such as Mounjaro or Wegovy, and the oral non-prescription treatment option, Orlos. Licensed clinicians assess each individual’s medical history, suitability, and contraindications to guide appropriate treatment decisions. Critically, all customers have access to comprehensive support, including 24/7 care team access and content to help improve nutrition, movement, and sleep-based habits along their weight loss journey. This holistic programme is designed to support long-term health, helping customers manage their weight and adopt sustainable lifestyle habits.
Now for the first time through Hers, women in the UK deemed clinically suitable can access a new standard of weight management care that blends convenience with personalised support at every step of their journey. Hers’ customers receive ongoing clinician support through follow-ups and asynchronous messaging, along with treatment adjustments when necessary, keeping care seamless, conversational, and customer-centered. Hers is more than just a telehealth platform; it's where clinical experience meets thoughtful care, resetting women’s expectations and standards for comprehensive and convenient care.
"The launch of Hims & Hers’ comprehensive Weight Loss Programme and the vital introduction of the Hers platform, our dedicated platform for women, represents a significant deepening of our commitment to the UK,” said David Meinertz, GM International of Hims & Hers. “Our doctor-designed treatment plans will complement the NHS by providing accessible, evidence-based, and sustainable long-term weight management care to those who need it, discreetly and conveniently. Our proven model is grounded in clinical excellence, oversight, and convenience, ensuring that every customer receives the thoughtful, thorough, and high-quality care they deserve."
"Obesity is a global epidemic, and the scale of the challenge in the UK requires a comprehensive solution that prioritises long-term health over quick fixes," said Craig Primack MD, Head of Weight Loss at Hims & Hers. "Bringing our trusted, comprehensive approach to the UK will help people lead fuller and healthier lives. And with the launch of the Hers platform, we are ensuring women have access to the dedicated, personalised care they need. Pairing clinically-proven treatments like GLP-1s with holistic support across nutrition and exercise helps make sustainable weight management achievable for the millions battling obesity today."
Launching its Weight Loss Programme marks the company’s continued progress in its mission to make personalised care accessible to millions of people across the UK. Hims & Hers plans to continue to expand into more offerings as demand for access to personalised care continues to grow.
About Hims & Hers Health, Inc
Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalises health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy achievable. No two people are the same, so the company provides access to personalised care designed for progress. For more information, please visit www.forhims.co.uk and www.forhers.co.uk
This communication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “assume,” “may,” “will,” “likely,” “potential,” “projects,” “predicts,” “continue,” “goal,” “strategy,” “future,” “forecast,” “target,” “outlook,” “opportunity,” “project,” “confidence,” “foundation,” “groundwork,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, statements regarding our launch and expansion of the program, the introduction of the Hers platform in the UK, our expectations regarding customer adoption and subscriber growth, the pricing and availability of GLP-1 or other treatment options, our market opportunity in the UK, the growth of our weight management offering internationally, and our ability to comply with applicable legal, regulatory, and clinical requirements in the UK and other markets. These statements are based on management’s current expectations, but actual results may differ materially due to various factors.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained in this communication are based on our current expectations, assumptions, and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the performance and acceptance of our weight loss specialty in the UK; our ability to successfully launch and scale the Hers platform in the UK; uncertainties relating to the availability, pricing, or supply of GLP-1 medications; changes in medical guidelines or regulatory requirements in the UK; competitive developments; operational and marketing costs; the impact of macroeconomic conditions on consumer demand; and other factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other reports we file from time to time with the Securities and Exchange Commission.
Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The forward-looking statements contained in this communication are made only as of December 10, 2025. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those made in or suggested by the forward-looking statements in this communication.
Dominic Soon, the Head of APAC Credit Research at Debtwire, discusses China Vanke's liquidity troubles and touches on what this could mean for the broader Chinese property sector,
2025-12-10 09:0423d ago
2025-12-10 03:3623d ago
Hims and Hers to offer weight-loss treatments in UK
Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United Kingdom which will include drugs like Novo Nordisk's Wegovy, the company said on Wednesday.
SummaryBlock, Inc. is rated a buy as Cash App drives robust growth, with margins at all-time highs and shares trading at a steep discount.XYZ raised full-year guidance, expecting adjusted operating income of $2.056 billion, up 28%, despite Q3 earnings and revenue missing analyst expectations.Cash App, now with 58 million monthly actives, leads gross profit growth and is rapidly expanding among younger generations and primary banking users.XYZ’s valuation metrics—PE, PB, and PS ratios—are well below historical levels, supporting a compelling entry point as the firm’s financial ecosystem gains traction. Alistair Berg/DigitalVision via Getty Images
Block, Inc. (XYZ) (BSQKZ) currently trades just above $60 a share with a market cap of $37.2 billion. The fintech powerhouse traded at a similar price in 2019 pre-pandemic. XYZ reached $270 per share in 2021
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Quick Insights
Recommended For You
2025-12-10 09:0423d ago
2025-12-10 03:4023d ago
Civitas Resources: Upgrading To Buy On Transformational Merger With SM Energy
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Europe's second-highest court on Wednesday rejected U.S. chipmaker Intel's challenge against a 376 million euros ($438 million) EU antitrust fine imposed two years ago for thwarting rivals, but cut the fine by 140 million euros.
SummaryTSMC offers attractive fundamentals and valuation amid the AI boom, commanding 38% global foundry market share and ~43% net income margin.TSM's pure-play foundry model and technological moat underpin its dominant position, but geopolitical risks—especially China-Taiwan tensions—pose significant downside threats.China’s push for semiconductor self-sufficiency could eventually threaten TSMC’s global dominance, though such risks remain longer-term.I rate TSMC a buy, but investors must monitor geopolitical developments and be ready to react swiftly to emerging threats. Getty Images
The Taiwan Semiconductor Manufacturing Company (TSM), colloquially referred to as TSMC, is the world’s foremost semiconductor manufacturing foundry and has been enjoying incredible tailwinds due to the ongoing AI boom. The PE ratio looks quite attractive for a
Analyst’s Disclosure:I/we have a beneficial long position in the shares of INTC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
I may go long on TSM in the near future.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
2025-12-10 09:0423d ago
2025-12-10 03:4723d ago
Ligand Pharmaceuticals Incorporated (LGND) Analyst/Investor Day Transcript
The Andersons, Inc. (ANDE) Analyst/Investor Day December 9, 2025 9:00 AM EST
Company Participants
Michael Hoelter - VP, Corporate Controller & Investor Relations
William Krueger - CEO, President & Director
Weston Heide - Executive Vice President of Agribusiness
Mark Simmons - Executive Vice President of Renewables Segments
Sarah Zibbel - Executive VP & Chief Human Resources Officer
Brian Valentine - Executive VP & CFO
Conference Call Participants
Pooran Sharma - Stephens Inc., Research Division
Benjamin Mayhew - BMO Capital Markets Equity Research
Kristen Owen - Oppenheimer & Co. Inc., Research Division
Benjamin Klieve - The Benchmark Company, LLC, Research Division
Conversation
Michael Hoelter
VP, Corporate Controller & Investor Relations
Good morning, everyone. Thank you for joining us for today for The Andersons 2025 Investor Day. We're excited to have you here, whether in person or virtually. For those of you that don't know me, I'm Mike Hoelter, Vice President, Corporate Controller and Investor Relations. And I've been with The Andersons for about 12 years, holding several financial roles within company.
Today is an opportunity for us to share our strategy, provide deeper insight into our business and discuss how we're positioning ourselves for long-term growth and value creation.
Before we begin, I'd like to draw your attention to the safe harbor statement on the screen. This contains important information regarding forward-looking statements. Please review it carefully as our remarks today may include projections and expectations that involve risks and uncertainties. Actual results may differ materially from those discussed, and we encourage you to review our SEC filings for a full discussion of risk factors. Our website also contains a copy of today's presentation slides.
Let me quickly walk you through what you can expect to hear today. We'll start with an overview of our company vision and long-term strategy led by our President and CEO, Bill Krueger. Next, you'll hear from
Recommended For You
2025-12-10 09:0423d ago
2025-12-10 03:5023d ago
Designer Brands Q3: A Clear EPS Beat, But Not Good Enough
Designer Brands Inc. reported a clear EPS beat in Q3, sending the stock surging. The report still shows weak underlying trends. Comparable store sales remain weak, ultimately driving long-term earnings deterioration. Gross margin expansion through lower markdowns is a clear positive, but gains shouldn't be extrapolated far.
2025-12-10 09:0423d ago
2025-12-10 03:5723d ago
HSBC to pay about $300 million to settle French tax probe, Bloomberg News reports
HSBC Holdings is preparing to pay around $300 million to settle a French criminal probe into its alleged role in the “Cum-Cum” tax scandal, Bloomberg News reported on Wednesday, citing people familiar with the matter.
2025-12-10 09:0423d ago
2025-12-10 03:5723d ago
Zillow's Potential Is Not Reflected In This Low Price
Analyst’s Disclosure:I/we have a beneficial long position in the shares of Z, GOOG, META either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-10 09:0423d ago
2025-12-10 03:5923d ago
Sibanye Stillwater: 'All-Weather' Metals Portfolio Paying Out Big Time
Sibanye Stillwater is reiterated as a Buy, with a unique multi-commodity portfolio and strong Q3 results. SBSW's EBITDA tripled on higher realized prices; a robust cash position and manageable net debt underpin financial strength. The company benefits from elevated precious and industrial metal prices, proactive power security, and a better-than-expected $215M settlement.
2025-12-10 09:0423d ago
2025-12-10 04:0023d ago
Linear Minerals Corp. acquires the Kipawa West Rare Earth Project, Quebec
VANCOUVER, BC / ACCESS Newswire / December 10, 2025 / Linear Minerals Corp. (CSE:LINE)(OTCID:LINMF)(WKN:A40 Y3E) ("Linear" or the "Company") is pleased to announce that it has entered into an option agreement to acquire a 100% interest into the Kipawa West rare earth Property in the administrative region of Abitibi‑Témiscamingue, Quebec, Canada.
The newly acquired property consists of 53 map designated claims mining claims covering an approximate area of 3,000 hectares located approximately 30 km east of the town Témiscaming and roughly 140 km south of the mining center of Rouyn‑Noranda. The strategic mineral exploration license is located about 15 km to the west of the Kipawa rare earth deposit in Quebec. Eight property claims have been approved; 45 are pending approval from MRNF Quebec. This land position places the Company in an important active district recognized for its rare earth enrichment, favorable geology, and increasing investor attention.
The Kipawa West claims cover peralkaline syenites with associated gneisses, amphibolites, calc-silicate rocks, marbles, and peralkaline gneissic granites of the Grenville Province of southwestern Quebec. This region has long been regarded as one prospective for rare earth elements exploration, characterized by unique alkaline intrusive complexes and well-documented critical mineral showings. Historical sediment sampling within the Property area indicate anomalous cerium and lanthanum values.
Within the Kipawa Complex, the nearby Kipawa Rare Earth deposit contains historic NI 43-101 resources last updated in a Feasibility Study published on September 04, 2013. The deposit is noted as being relatively rich in heavy rare earths (HREE), which are among the most desirable REEs for many high-tech and clean-energy uses. The project was originally explored by Matamec Explorations Inc. in partnership with Toyotsu Rare Earth Canada Inc (TRECAN).
Cautionary Statement: Readers are cautioned that the above information is taken from the publicly available sources and any reference to the Kipawa Deposit is provided for geological context only. The presence of mineral resources on an adjacent property does not indicate that similar mineralization or resource potential exists on the Company's property. Additional exploration work would be required to determine whether comparable mineralization is present.
With this acquisition, Linear Minerals strengthens its mission to identify and develop high-value critical mineral assets in politically stable, mining-friendly jurisdictions. The Company is reviewing historical data and preparing an initial work program, including mapping, sampling, and geophysical studies to define target areas for drilling.
Transaction details:
Pursuant to the Kipawa West rare-earth Property option agreement from an arm's length seller and the Company, dated December 9th, 2025 ("Effective date"), the Company holds an option to acquire a 100% interest in the mining claims by completing the following common share issuances and exploration expenditures as follows:
Issuing the following common shares to the Optionor, subject to the approval of the regulatory bodies as follows:
1,000,000 shares, issued upon the execution of the option agreement;
An additional 1,500,000 shares issued on or before the first anniversary of the Effective Date.
An additional 2,000,000 shares issued on or before the second anniversary of the Effective Date.
The Company incurring the following exploration expenditures on the property as follows:
$250,000 on or before the first anniversary of the Effective Date;
An additional $500,000 on or before the second anniversary of the Effective Date.
An additional $500,000 on or before the third anniversary of the Effective Date.
The Optionor will retain a 2.0 % GMR from any future production.
The issuance of the common shares is subject to obtaining all required regulatory approvals, including that of the Canadian Securities Exchange. The common shares will be subject to a hold period of four months and one day for their date of issuance.
On behalf of the board of directors.
"Gurminder Sangha"
CEO, Director
For further information, please contact the Company at: [email protected]
Forward Looking Statements
When used in this news release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although the Company believes, in light of the experience of their respective officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in the forward-looking statements and information in this news release are reasonable, undue reliance should not be placed on them because the parties can give no assurance that such statements will prove to be correct. The forward-looking statements and information in this news release include, amongst others, the Company's plans regarding the Arrangement. Such statements and information reflect the current view of the Company. There are risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information.
By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements or implied by such forward-looking statements. There are a number of important factors that could cause the Company's actual results to differ materially from those indicated or implied by forward-looking statements and information. Such factors include, among others: currency fluctuations; limited business history of the parties; disruptions or changes in the credit or security markets; results of operation activities and development of projects; project cost overruns or unanticipated costs; shareholder, court and regulatory approvals; and general development, market and industry conditions.
The Company undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of its securities or its financial or operating results (as applicable). The Company cautions that the foregoing list of material factors is not exhaustive. When relying on the Company's forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. The Company has assumed that the material factors referred to in the previous paragraph will not cause such forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.
The forward-looking information contained in this news release represents the expectations of the Company as of the date of this news release and, accordingly, are subject to change after such date. The Company does not undertake to update this information at any particular time except as required in accordance with applicable laws.
SOURCE: Linear Minerals Corp.
2025-12-10 09:0423d ago
2025-12-10 04:0023d ago
Rakovina Therapeutics Announces Upcoming Webinar with Variational AI
VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce that the Company will host a 60-minute webinar on December 17, 2025 at 10:00 AM PST.
The session, titled From Handshake to Breakthrough will bring together leaders from Rakovina Therapeutics and Variational AI for a fireside discussion on how the two companies are tackling one of oncology’s toughest design challenges: creating CNS-penetrant, multi-target cancer therapeutics. Using the AI-designed ATR/mTOR inhibitor program as a case study, the teams will outline how the partnership began, the biological hurdles they set out to overcome, and what the latest preclinical data mean for future development.
The webinar will conclude with an open Q&A, allowing participants to engage directly with both organizations.
Please RSVP for this event with the zoom link below:
About Rakovina Therapeutics Inc.
Rakovina Therapeutics is a biopharmaceutical research company focused on the development of innovative cancer treatments. Our work is based on unique technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using the proprietary Deep-Docking™ and Enki™ platforms. By using AI, we can review and optimize drug candidates at a much greater pace than ever before.
The Company has established a pipeline of distinctive DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners. Further information may be found at www.rakovinatherapeutics.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
Notice Regarding Rakovina Therapeutics Forward-Looking Statements:
This release includes forward-looking statements regarding the company and its respective business, which may include, but is not limited to, statements with respect to the proposed business plan of the company and other statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans,” “is expected,” “expects,” “scheduled,” “intends,” “contemplates,” “anticipates,” “believes,” “proposes” or variations (including negative variations) of such words and phrases, or state that certain actions, events, or results “may,” “could,” “would,” “might,” or “will” be taken, occur, or be achieved. Such statements are based on the current expectations of the management of the company. The forward-looking events and circumstances discussed in this release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the company, including risks regarding the biopharmaceutical industry, economic factors, regulatory factors, the equity markets generally, and risks associated with growth and competition.
Although the company has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events, or results to differ from those anticipated, estimated, or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made, and the company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. The reader is referred to the company’s most recent filings on SEDAR+ for a more complete discussion of all applicable risk factors and their potential effects, copies of which may be accessed through the company’s profile page at www.sedar.com.
For Further Information Contact:
Michelle Seltenrich, BSc MBA
Director, Corporate Development [email protected]
778-773-5432
2025-12-10 09:0423d ago
2025-12-10 04:0023d ago
BON Unveils Kombucha-Inspired Product, Inks $12 Million Strategic Sales Agreement with Qingshengyuan
, /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced the launch of a new health-focused kombucha-inspired product and a strategic collaboration with Shaanxi Qingshengyuan Health Industry Co., Ltd. ("Qingshengyuan"), a leading distributor of functional health products in China focusing on digestive and metabolic wellness. The two parties entered into a non-exclusive strategic sales agreement. The term of the agreement is 24 months with a total contract value of $12 million. Pursuant to the agreement, Qingshengyuan will sell and distribute BON's high-tea-pigment products across Greater China.
As a global innovator in tea-pigment ingredients, BON has observed growing consumer demand for tea-based products that are "more efficient, more pure, and more scientific." In response, the Company has developed a kombucha-inspired beverage produced from premium tea, sugar, and a Symbiotic Culture of Bacteria and Yeast ("SCOBY"). The product undergoes a controlled natural fermentation process that maintains the tea's fresh aroma, sweet aftertaste, and lightly effervescent texture, while enhancing the extraction and concentration of tea pigments. As a result, the beverage contains higher levels of tea pigments compared to similar products.
Kombucha has become one of the fastest-growing functional beverage categories in recent years, driven by consumer interest in natural ingredients and perceived health benefits, particularly among younger consumers. BON's product is designed to align with these market trends and seeks to support category development through its ingredient-focused technology.
Tea pigments are natural, water-soluble pigment complexes formed during the fermentation and oxidation of tea leaves and are considered key functional compounds in tea. Scientific literature indicates that tea pigments contribute to the color and clarity of tea infusions and have been the subject of research regarding potential biological properties, including antioxidant activity and other areas of scientific interest.
As consumer preferences increasingly shift toward natural ingredients and as the functional food and beverage market expands, tea pigments are gaining broader commercial application as an alternative to synthetic additives. They are used in tea beverages, health-oriented consumer products, and other ingredient formulations within the food and beverage industry.
Driven by these trends, the market for tea-pigment-based ingredients has continued to grow. Industry sources project that the overall market opportunity for tea-pigment applications could reach approximately $1 billion in the coming years.
Yongwei Hu, CEO and Chairman of BON, stated: "This strategic cooperation with Qingshengyuan represents an important step in expanding BON's presence in the functional product industry and supports the development and commercialization of our tea-pigment product portfolio. We expect that combining the resources and capabilities of both parties will help increase market awareness of our ingredient technologies and broaden the reach of our products among targeted consumer groups. Through this collaboration, we aim to advance product innovation, support broader adoption of health-focused concepts in the market, and further strengthen BON's positioning in both domestic and international markets. We believe this will support the Company's future revenue and earnings and further enhance long-term shareholder value."
About Bon Natural Life Limited ("BON")
BON is a Cayman Islands company engaged in the business of natural, health, and personal care industries. For more information, please visit the Company's website at http://www.bnlus.com.
For more information, please contact:
Cindy Liu | IR
Email: [email protected]
Safe Harbor Statement
This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes,""expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.